Ischemic heart disease — all decisions

The Board remands the claims for service connection for a cardiac disability and an initial compensable rating for hypertensive vascular disease to obtain additional medical evidence.

The Veteran withdrew the appeal for service connection for supraventricular arrhythmia, chronic paronychia, psoriasis and rosacea (claimed as skin condition), pulmonary nodules, and valvular heart disease.

The Board remands the claim for service connection for coronary artery disease to obtain an addendum opinion regarding the relationship between the Veteran's PTSD and his heart condition.

The appeal for special monthly pension (SMP) based on the need for regular aid and attendance or housebound status is remanded to ensure that the appellant receives every possible consideration, including a new VA examination.

The Board denied service connection for diabetes mellitus, valvular heart disease (chest pain and cardiac valve stenosis), aortic aneurysm, and hypertension as these conditions were not found to be etiologically related to the Veteran's active duty service.

The Board granted an earlier effective date of July 31, 2018, for the 60 percent rating for coronary artery disease with sinus bradycardia status post myocardial infarction.

The Board granted a 60 percent disability rating for chronic coronary artery disease (CAD) but denied a higher rating for chronic kidney disease.

The Board denied service connection for ischemic heart disease (IHD) for purposes of establishing entitlement to retroactive benefits as a Nehmer class member.

The Veteran is granted a total disability rating based on individual unemployability due to coronary artery disease with atrial fibrillation from April 10, 2012, and special monthly compensation (SMC) under 38 U.S.C. § 1114(s) based on housebound status from April 10, 2013.

The Board granted readjudication of the claims for service connection for headaches, a sleep condition (OSA), Parkinsonism (including Parkinson's disease), unspecified depressive disorder, CAD with atrial fibrillation, bilateral upper extremity neuropathy, and bilateral lower extremity neuropathy based on new evidence. The claim for hyperhidrosis was denied as no new relevant evidence was received.

The Board granted service connection for a heart disability, resolving reasonable doubt in favor of the Veteran and finding that his condition is related to environmental exposures during service.

The Board granted an earlier effective date of January 15, 2011, for a 60 percent rating coronary artery disease, status-post myocardial infarction.

The Board remands the claims for service connection for a heart disorder, hypertension, and AL amyloidosis due to an incomplete duty to assist regarding potential herbicide exposure.

The Board denied the veteran's claims for a higher initial disability rating and TDIU, finding that his service-connected conditions did not meet the criteria for increased ratings or unemployability.

The Board granted service connection for a heart disability, to include aortic valve stenosis, CAD, coronary artery bypass surgery and aortic valve replacement, based on the Veteran's exposure to contaminated water at Camp Lejeune.

The Board remands the claims for service connection for the cause of the Veteran's death and accrued benefits due to pending asbestos exposure development.

The Board granted a total disability rating for compensation based on individual unemployability (TDIU) due to service-connected disabilities effective July 29, 2019, but not earlier.

The Board remands the matters of entitlement to an increased rating for coronary artery disease, a total disability rating based on individual unemployability (TDIU), and basic eligibility to Dependents' Educational Assistance (DEA) for further development.

The Board granted a 100 percent disability rating for arteriosclerotic heart disease from April 19, 2021 to September 5, 2024 and denied a higher rating thereafter.

The Board remands the claims for service connection for various disabilities and an increased rating for skin cancer to correct duty-to-assist errors.